Clinical Trials Browser

Phase 1 × INDUSTRY × Lisaftoclax × Clear all

NCT03913949 2026-05-01

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04260217 2025-08-19

MAPLE-1

Phase 1 Completed

Waldenstrom Macroglobulinemia

NCT05701306 2025-02-25

APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

Phase 1 Recruiting

Neuroblastoma